MERCK KGAA (MRK.DE) Stock Price, Forecast & Analysis

Europe • Frankfurt Stock Exchange • FRA:MRK • DE0006599905

126.3 EUR
+0.75 (+0.6%)
Last: Feb 2, 2026, 05:35 PM

MRK.DE Key Statistics, Chart & Performance

Key Statistics
Market Cap54.91B
Revenue(TTM)21.27B
Net Income(TTM)2.96B
Shares434.78M
Float129.24M
52 Week High145.2
52 Week Low100.7
Yearly Dividend0.65
Dividend Yield1.75%
EPS(TTM)8.53
PE14.81
Fwd PE14.69
Earnings (Next)03-05
IPO1995-10-20
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
MRK.DE short term performance overview.The bars show the price performance of MRK.DE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 10 15

MRK.DE long term performance overview.The bars show the price performance of MRK.DE in the last 1, 2 and 3 years. 1 year 2 years 3 years -10 -20 -30

The current stock price of MRK.DE is 126.3 EUR. In the past month the price increased by 3.5%. In the past year, price decreased by -14.24%.

MERCK KGAA / MRK Daily stock chart

MRK.DE Technical Analysis

ChartMill assigns a technical rating of 6 / 10 to MRK.DE. When comparing the yearly performance of all stocks, MRK.DE is a bad performer in the overall market: 71.14% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

MRK.DE Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to MRK.DE. MRK.DE has an average financial health and profitability rating.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

MRK.DE Financial Highlights

Over the last trailing twelve months MRK.DE reported a non-GAAP Earnings per Share(EPS) of 8.53. The EPS increased by 1.43% compared to the year before.


Industry RankSector Rank
PM (TTM) 13.89%
ROA 5.8%
ROE 10.21%
Debt/Equity 0.36
Chartmill High Growth Momentum
EPS Q2Q%0.87%
Sales Q2Q%0.99%
EPS 1Y (TTM)1.43%
Revenue 1Y (TTM)1.47%

MRK.DE Forecast & Estimates

23 analysts have analysed MRK.DE and the average price target is 149.24 EUR. This implies a price increase of 18.16% is expected in the next year compared to the current price of 126.3.

For the next year, analysts expect an EPS growth of -0.97% and a revenue growth 0.36% for MRK.DE


Analysts
Analysts79.13
Price Target149.24 (18.16%)
EPS Next Y-0.97%
Revenue Next Year0.36%

MRK.DE Ownership

Ownership
Inst Owners54.91%
Ins OwnersN/A
Short Float %N/A
Short RatioN/A

About MRK.DE

Company Profile

MRK logo image Merck KGaA is a science and technology company, which engages in the manufacture of pharmaceutical and chemical products. The company is headquartered in Darmstadt, Hessen and currently employs 62,346 full-time employees. The firm operates in three business segments: Healthcare, Life Sciences and Electronics. The Healthcare business, which operates in the United States and Canada as EMD Serono, focuses on such therapeutic areas as allergies, fertility, oncology and neurodegenerative diseases, developing drugs, diagnostic substances and medical devices. The Life Sciences business comprises the activities of MilliporeSigma, which provides solutions that facilitate biotechnology and pharmaceutical research. The product range includes laboratory water systems, gene editing tools, cell lines and end-to-end drug manufacturing systems, among others. The Electronics business enables digital living and provides specialty chemicals for various applications, including liquid crystals for electronic displays, materials for integrated circuits, effect pigments for coatings and color cosmetics, as well as functional materials for energy solutions.

Company Info

MERCK KGAA

Frankfurter Strasse 250

Darmstadt HESSEN DE

Employees: 59020

MRK Company Website

MRK Investor Relations

Phone: 496151720

MERCK KGAA / MRK.DE FAQ

What does MRK do?

Merck KGaA is a science and technology company, which engages in the manufacture of pharmaceutical and chemical products. The company is headquartered in Darmstadt, Hessen and currently employs 62,346 full-time employees. The firm operates in three business segments: Healthcare, Life Sciences and Electronics. The Healthcare business, which operates in the United States and Canada as EMD Serono, focuses on such therapeutic areas as allergies, fertility, oncology and neurodegenerative diseases, developing drugs, diagnostic substances and medical devices. The Life Sciences business comprises the activities of MilliporeSigma, which provides solutions that facilitate biotechnology and pharmaceutical research. The product range includes laboratory water systems, gene editing tools, cell lines and end-to-end drug manufacturing systems, among others. The Electronics business enables digital living and provides specialty chemicals for various applications, including liquid crystals for electronic displays, materials for integrated circuits, effect pigments for coatings and color cosmetics, as well as functional materials for energy solutions.


Can you provide the latest stock price for MERCK KGAA?

The current stock price of MRK.DE is 126.3 EUR. The price increased by 0.6% in the last trading session.


What is the dividend status of MERCK KGAA?

MERCK KGAA (MRK.DE) has a dividend yield of 1.75%. The yearly dividend amount is currently 0.65.


How is the ChartMill rating for MERCK KGAA?

MRK.DE has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 4 out of 10.


What is the analyst forecast for MRK.DE stock?

23 analysts have analysed MRK.DE and the average price target is 149.24 EUR. This implies a price increase of 18.16% is expected in the next year compared to the current price of 126.3.


How many employees does MERCK KGAA have?

MERCK KGAA (MRK.DE) currently has 59020 employees.


What is the next earnings date for MRK stock?

MERCK KGAA (MRK.DE) will report earnings on 2026-03-05, after the market close.